Biochemistry analyzer market seen rising to $6.29 billion by 2030

The biochemistry analyzer market is projected to grow from $4.58 billion in 2025 to $4.88 billion in 2026, according to a new report from The Business Research Company. The report links the expansion to higher hospital testing volumes, chronic disease burden and broader use of automated clinical chemistry systems in diagnostics and research.

Why it matters: - Biochemistry analyzers support faster diagnosis and monitoring by measuring enzymes, electrolytes, proteins and other biochemical markers in biological samples. - Rising demand for clinical testing, routine screening and rapid diagnostics is expanding use across hospitals, diagnostic centers, biopharmaceutical research and academic labs. - Cardiovascular disease is adding pressure to testing volumes, since providers rely on biochemical markers to assess risk and guide treatment.

What happened: - The Business Research Company released a biochemistry analyzer market report on July 29, 2026. - The report estimates the market will rise from $4.58 billion in 2025 to $4.88 billion in 2026. - The report projects the market will reach $6.29 billion by 2030. - The report uses a 6.6% compound annual growth rate for both the near-term and long-term forecast period. - The report says Europe was the largest regional market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - Download a free sample of the biochemistry analyzer market report. - View the full biochemistry analyzer market report.

The details: - The report ties 2026 growth to rising hospital laboratory testing volumes, early adoption of automated clinical chemistry analyzers, expanding diagnostic center infrastructure, higher rates of chronic and metabolic disease, and the use of biochemistry testing in routine health screenings. - The longer-term outlook is supported by demand for high-throughput analyzer platforms, broader use in biopharmaceutical research and development, adoption by academic and contract research organizations, and tighter demand for rapid, accurate diagnostic workflows. - The report also points to growing clinical diagnostics activity in emerging healthcare markets as a demand driver. - Key trends include more frequent use in routine diagnostics, demand for fast-result testing systems, wider use in drug development and continued focus on accuracy and standardization. - A biochemistry analyzer is a laboratory device used to quantify biochemical substances in biological samples. - The instrument triggers chemical reactions in samples and quickly returns results to support diagnosis and monitoring. - In January 2024, the American Heart Association reported 931,578 cardiovascular deaths in the US for 2024, up from 928,741 in 2023. - The American Heart Association also reported an age-adjusted cardiovascular death rate of 233.3 per 100,000 in 2024, up from 224.4 per 100,000 in 2023. - The report’s 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspot infographics, key technologies and future trend analysis, and updated graphics and tables.

Between the lines: - The forecast suggests biochemistry analyzers are shifting from a narrow lab function to a broader role in routine care, drug development and distributed diagnostics. - Europe’s position as the largest regional market points to mature diagnostic infrastructure, while the report’s focus on emerging markets signals where future volume growth may come from. - The combination of automation, speed and standardization reflects pressure on labs to handle more tests with fewer delays and more consistent results.

What's next: - Demand will likely stay tied to chronic disease prevalence, especially cardiovascular and metabolic conditions. - Growth will also depend on how quickly hospitals, diagnostic centers and research organizations adopt higher-throughput systems. - The report expects continued expansion through 2030 at a 6.6% CAGR. - The Business Research Company provided contact details for expert inquiries and global sales support, including email and regional phone numbers.